CoChat

HMOX1 Gene Promoter Alleles and High HO-1 Levels Are Associated with Severe Malaria in Gambian Children

Open access

The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.

Abstract

Heme oxygenase 1 (HO-1) is an essential enzyme induced by heme and multiple stimuli associated with critical illness. In humans, polymorphisms in the HMOX1 gene promoter may influence the magnitude of HO-1 expression. In many diseases including murine malaria, HO-1 induction produces protective anti-inflammatory effects, but observations from patients suggest these may be limited to a narrow range of HO-1 induction, prompting us to investigate the role of HO-1 in malaria infection. In 307 Gambian children with either severe or uncomplicated P. falciparum malaria, we characterized the associations of HMOX1 promoter polymorphisms, HMOX1 mRNA inducibility, HO-1 protein levels in leucocytes (flow cytometry), and plasma (ELISA) with disease severity. The (GT)(n) repeat polymorphism in the HMOX1 promoter was associated with HMOX1 mRNA expression in white blood cells in vitro, and with severe disease and death, while high HO-1 levels were associated with severe disease. Neutrophils were the main HO-1-expressing cells in peripheral blood, and HMOX1 mRNA expression was upregulated by heme-moieties of lysed erythrocytes. We provide mechanistic evidence that induction of HMOX1 expression in neutrophils potentiates the respiratory burst, and propose this may be part of the causal pathway explaining the association between short (GT)(n) repeats and increased disease severity in malaria and other critical illnesses. Our findings suggest a genetic predisposition to higher levels of HO-1 is associated with severe illness, and enhances the neutrophil burst leading to oxidative damage of endothelial cells. These add important information to the discussion about possible therapeutic manipulation of HO-1 in critically ill patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.ppat.1002579

Cites

106 of 106 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Neutrophils are the main HO-1 expressing cell type in peripheral blood. Whole blood from 16 SM and 21 UM cases was stained for A) intracellular HO-1 expression [plots 3 and 4 in the first row show the isotype control], and B) for lineage markers defining neutrophils (CD16b), T cells (CD3), monocytes (CD14), and B cells (CD19). Dendritic cells were defined as lineage marker negative HLA-DR pos cells. C) HO-1 positive cells were displayed according to expression of lineage markers. D) Neutrophils, T cells, monocytes, B cells and DCs were displayed according to HO-1 expression. The Y axis in all plots is the side scatter (SSC). E) Proportion of white blood cell subsets staining for HO-1. F) representative Western blot showing HO-1 immunoreactive protein in purified granulocytes [G = granulocytes, kDa = molecular weight maker] G) Percentage of HO-1 pos cells according to white blood cell subsets. S = severe; U = uncomplicated cases; HC = healthy controls; D0 = day 0; D28 = day 28. The median with 95% CI is shown for 16 severe, 21 uncomplicated cases and 6 healthy controls.
Figure 1 Neutrophils are the main HO-1 expressing cell type in peripheral blood. Whole blood from 16 SM and 21 UM cases was stained for A) intracellular HO-1 expression [plots 3 and 4 in the first row show the isotype control], and B) for lineage markers defining neutrophils (CD16b), T cells (CD3), monocytes (CD14), and B cells (CD19). Dendritic cells were defined as lineage marker negative HLA-DR pos cells. C) HO-1 positive cells were displayed according to expression of lineage markers. D) Neutrophils, T cells, monocytes, B cells and DCs were displayed according to HO-1 expression. The Y axis in all plots is the side scatter (SSC). E) Proportion of white blood cell subsets staining for HO-1. F) representative Western blot showing HO-1 immunoreactive protein in purified granulocytes [G = granulocytes, kDa = molecular weight maker] G) Percentage of HO-1 pos cells according to white blood cell subsets. S = severe; U = uncomplicated cases; HC = healthy controls; D0 = day 0; D28 = day 28. The median with 95% CI is shown for 16 severe, 21 uncomplicated cases and 6 healthy controls.CC0 · PubMed Central
Figure 2 HMOX1 mRNA and HO-1 protein are upregulated in acute malaria, being highest in cases with SRD. HMOX1 mRNA levels measured in whole blood are shown comparing A) severe (n = 128) and uncomplicated (n = 134) cases over time, and B) different disease entities on day 0. HO-1 plasma concentrations are shown comparing C) severe (n = 138) and uncomplicated (n = 137) cases over time, and D) different disease entities on day 0. P values shown in A) and C) are derived from the random effects regression model, adjusting for age, gender, duration of symptoms and neutrophil counts. P values shown in B) and D) are from a linear regression model adjusting for age, gender, duration of symptoms, neutrophil counts and Hb. S = severe, U = uncomplicated, D0 = day 0, D28 = day 28. SRD = severe respiratory distress, CM = cerebral malaria, SA = severe anaemia, SP = severe prostration, UM = uncomplicated malaria. The red lines represent the medians.
Figure 2 HMOX1 mRNA and HO-1 protein are upregulated in acute malaria, being highest in cases with SRD. HMOX1 mRNA levels measured in whole blood are shown comparing A) severe (n = 128) and uncomplicated (n = 134) cases over time, and B) different disease entities on day 0. HO-1 plasma concentrations are shown comparing C) severe (n = 138) and uncomplicated (n = 137) cases over time, and D) different disease entities on day 0. P values shown in A) and C) are derived from the random effects regression model, adjusting for age, gender, duration of symptoms and neutrophil counts. P values shown in B) and D) are from a linear regression model adjusting for age, gender, duration of symptoms, neutrophil counts and Hb. S = severe, U = uncomplicated, D0 = day 0, D28 = day 28. SRD = severe respiratory distress, CM = cerebral malaria, SA = severe anaemia, SP = severe prostration, UM = uncomplicated malaria. The red lines represent the medians.CC0 · PubMed Central
Figure 3 Hemin and lysed RBC can induce HMOX1 mRNA in neutrophils. Induction of HMOX1 mRNA in bead-isolated neutrophils is shown in response to 3 hours stimulation with growth medium (GM), intact uninfected RBC, a lysate of uninfected RBC, P. falciparum Schizont extract (PfSE), or hemin. Experiments were repeated independently 7 times. Wilcoxon matched pairs test was performed with p-values adjusted for multiple comparisons using Holm step down procedure. Box plots show medians and interquartile ranges.
Figure 3 Hemin and lysed RBC can induce HMOX1 mRNA in neutrophils. Induction of HMOX1 mRNA in bead-isolated neutrophils is shown in response to 3 hours stimulation with growth medium (GM), intact uninfected RBC, a lysate of uninfected RBC, P. falciparum Schizont extract (PfSE), or hemin. Experiments were repeated independently 7 times. Wilcoxon matched pairs test was performed with p-values adjusted for multiple comparisons using Holm step down procedure. Box plots show medians and interquartile ranges.CC0 · PubMed Central
Figure 4 Hemin-induced HMOX1 induction primes the oxidative burst of neutrophils. In 8 independent experiments, whole blood from different donors was incubated for 18 hours with increasing amounts of hemin in the presence or absence of 10 µM SnPP and the neutrophil oxidative burst induced by PMA was quantified by flow cytometric assessment of oxidation of dihydrorhodamine 123 into the fluorescent rhodamine. A) HMOX1 mRNA levels induced by various concentrations of hemin. B) Viability of neutrophils after 18 hrs pre-incubation with 0–200 µM hemin. C) Proportion of neutrophils that mount an oxidative burst, defined as positive rhodamine fluorescence. D) Magnitude of the oxidative burst in neutrophils in response to stimulation with 0–1 µM PMA after 18 hrs pre-incubation with 0–200 µM hemin. E) Magnitude of the oxidative burst in neutrophils in response to 0.1 µM PMA after 18 hrs pre-incubation with 0–200 µM hemin with or without addition of 10 µM SnPP. The mean and SE are shown. MFI: median fluorescence intensity.
Figure 4 Hemin-induced HMOX1 induction primes the oxidative burst of neutrophils. In 8 independent experiments, whole blood from different donors was incubated for 18 hours with increasing amounts of hemin in the presence or absence of 10 µM SnPP and the neutrophil oxidative burst induced by PMA was quantified by flow cytometric assessment of oxidation of dihydrorhodamine 123 into the fluorescent rhodamine. A) HMOX1 mRNA levels induced by various concentrations of hemin. B) Viability of neutrophils after 18 hrs pre-incubation with 0–200 µM hemin. C) Proportion of neutrophils that mount an oxidative burst, defined as positive rhodamine fluorescence. D) Magnitude of the oxidative burst in neutrophils in response to stimulation with 0–1 µM PMA after 18 hrs pre-incubation with 0–200 µM hemin. E) Magnitude of the oxidative burst in neutrophils in response to 0.1 µM PMA after 18 hrs pre-incubation with 0–200 µM hemin with or without addition of 10 µM SnPP. The mean and SE are shown. MFI: median fluorescence intensity.CC0 · PubMed Central
Figure 5 Other factors associated with HMOX1 mRNA expression. A) HMOX1 mRNA was measured in whole blood from convalescent SM (n = 12) and UM (n = 14) cases and healthy controls (HC, n = 6). For 3 hours, blood was kept in a water bath at 37°C, 40°C or stimulated at room temperature with hemin. Measurements within each group (SM, UM, HC) were compared using the Friedman test, (a non-parametric ANOVA for repeated measures) with Dunn's post-test adjustment for multiple comparisons. Differences between SM and UM for hemin or heat induction were assessed using the Mann Whitney test. The red lines indicate the medians. * p≤0.05, ** p≤0.005, *** p≤0.0005. mRNA levels for HMOX1 and IL-10 measured on day 0 were correlated for B) 58 SM [r: 0.59, p<0.0001] and C) 59 UM cases [r: 0.37, p = 0.0037].
Figure 5 Other factors associated with HMOX1 mRNA expression. A) HMOX1 mRNA was measured in whole blood from convalescent SM (n = 12) and UM (n = 14) cases and healthy controls (HC, n = 6). For 3 hours, blood was kept in a water bath at 37°C, 40°C or stimulated at room temperature with hemin. Measurements within each group (SM, UM, HC) were compared using the Friedman test, (a non-parametric ANOVA for repeated measures) with Dunn's post-test adjustment for multiple comparisons. Differences between SM and UM for hemin or heat induction were assessed using the Mann Whitney test. The red lines indicate the medians. * p≤0.05, ** p≤0.005, *** p≤0.0005. mRNA levels for HMOX1 and IL-10 measured on day 0 were correlated for B) 58 SM [r: 0.59, p<0.0001] and C) 59 UM cases [r: 0.37, p = 0.0037].CC0 · PubMed Central
Figure 6 Long (GT)n repeats and “L carrier” genotype associate with less severe disease. A) Frequency distribution of the number of [GT]n repeats in SM (open bars, n = 282 alleles) and UM cases (black bars, n = 302 alleles). B) Frequency of the “S” (short<27), “M” (medium 27 to 32) and L (long>32) [GT]n repeats for SM (open bars) and UM (black bars) cases. C) Frequency of “S” (open bars), “M” (dotted bars) and “L” (black bars) [GT]n repeats according to disease entities. Distribution of HMOX1 promoter genotypes amongst D) SM (open bars) and UM (black bars) cases, and E) amongst different disease entities. Those labeled in green are “L carriers”, those labeled in red are “non-L carriers”. SM = severe malaria, SRD = severe respiratory distress, CM = cerebral malaria, SA = severe anaemia, SP = severe prostration, UM = uncomplicated malaria.
Figure 6 Long (GT)n repeats and “L carrier” genotype associate with less severe disease. A) Frequency distribution of the number of [GT]n repeats in SM (open bars, n = 282 alleles) and UM cases (black bars, n = 302 alleles). B) Frequency of the “S” (short<27), “M” (medium 27 to 32) and L (long>32) [GT]n repeats for SM (open bars) and UM (black bars) cases. C) Frequency of “S” (open bars), “M” (dotted bars) and “L” (black bars) [GT]n repeats according to disease entities. Distribution of HMOX1 promoter genotypes amongst D) SM (open bars) and UM (black bars) cases, and E) amongst different disease entities. Those labeled in green are “L carriers”, those labeled in red are “non-L carriers”. SM = severe malaria, SRD = severe respiratory distress, CM = cerebral malaria, SA = severe anaemia, SP = severe prostration, UM = uncomplicated malaria.CC0 · PubMed Central
Figure 7 Higher HMOX1 mRNA induction in peripheral blood from “non-L allele” carriers in response to hemin. Induction of HMOX1 mRNA after 3 hrs exposure to 40°C or 100 µM hemin is shown according to L/non L carrier status for 26 individuals, using blood collected on D28. The red line represents the median. Raw p values are reported. After Bonferroni's adjustment for multiple comparisons the significance threshold becomes 0.007.
Figure 7 Higher HMOX1 mRNA induction in peripheral blood from “non-L allele” carriers in response to hemin. Induction of HMOX1 mRNA after 3 hrs exposure to 40°C or 100 µM hemin is shown according to L/non L carrier status for 26 individuals, using blood collected on D28. The red line represents the median. Raw p values are reported. After Bonferroni's adjustment for multiple comparisons the significance threshold becomes 0.007.CC0 · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 106 references

Cited by

See all 98

Metadata

Authors
Walther, M., De Caul, A., Aka, P., Njie, M., Amambua-Ngwa, A., Walther, B., Predazzi, I. M., Cunnington, A., Deininger, S., Takem, E. N., Ebonyi, A., Weis, S., Walton, R., Rowland-Jones, S., Sirugo, G., Williams, S. M., & Conway, D. J.
Affiliations
  • National Institutes of Health (US)
  • Vanderbilt University (US)
  • London School of Hygiene & Tropical Medicine (GB)
  • University Hospital Bonn (DE)
  • Leipzig University (DE)
  • Queen Mary University of London (GB)
  • Ospedale San Pietro Fatebenefratelli (IT)
Corresponding author
Walther, Michael
Venue
PLoS Pathogens
Published
2012-03-15
Volume
8
Issue
3
Pages
e1002579
ISSN
  • 1553-7366 (ISSN-L)
  • 1553-7374
OpenAlex
W2128312300
Cited by
98
References
105
Citations by year
2026: 4 · 2025: 3 · 2024: 2 · 2023: 2 · 2022: 7 · 2021: 7 · 2020: 8 · 2019: 7 · 2018: 13 · 2017: 5 · 2016: 9 · 2015: 12 · 2014: 7 · 2013: 7 · 2012: 5
FWCI
3.99
Type
journal article
Language
en
Open access
Locations
  • PLoS Pathogens (publishedVersion, public-domain)
  • PubMed Central (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
  • Minerva Access (University of Melbourne) (submittedVersion)
  • Queen Mary Research Online (Queen Mary University of London) (submittedVersion, public-domain)
  • Spiral (Imperial College London) (submittedVersion, public-domain)
  • Greater South Information System
  • University of Warwick (cc-by)
Funders
  • University of Oxford
  • National Institutes of Health
  • Medical Research Council
  • National Heart, Lung, and Blood Institute (T32HL007751)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heme Oxygenase-1 and Carbon Monoxide
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
  • Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
Keywords
heme oxygenase-1, severe malaria, Plasmodium falciparum, promoter polymorphism, (GT)n repeat, genetic susceptibility, neutrophils, respiratory burst, heme, disease severity, children, oxidative stress, endothelial injury
MeSH terms
Child, Child, Preschool, Female, Gambia, Gene Frequency, Humans, Leukocytes, Male, Neutrophils, Polymorphism, Genetic, Promoter Regions, Genetic, RNA, Messenger, Gene Expression, Survival Rate, Malaria, Falciparum, Respiratory Burst, Genetic Predisposition to Disease, Heme Oxygenase-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.